NCT07586202
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07586202
Title A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC (AmiNA)
Acronym AmiNA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | CAN

Facility Status City State Zip Country Details
Princess Margaret Hospital RECRUITING Toronto Ontario M5G 2C1 Canada Details
West China Hospital Sichuan University RECRUITING Chengdu 610041 China Details
Guangdong Provincial People's Hospital RECRUITING Guangzhou 510060 China Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
Hosp. Gral. Univ. Dr. Balmis RECRUITING Alicante 03010 Spain Details
Hosp. Gral. Univ. Gregorio Maranon RECRUITING Madrid 28007 Spain Details
Chi Mei Medical Center Liouying Branch RECRUITING Tainan 736 Taiwan Details
Taipei Medical University Hospital RECRUITING Taipei 110 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field